Survival data from The Cancer Genome Atlas (TCGA) dataset shows that HNSCC patients with a high level of IL-8 have a significantly worse outcome than patients with a low level of IL-8 (Fig. 1d, P = 0.011). Here, CXCL8 is linked to head and neck squamous cell carcinoma.